AGENUS INC — Director's Dealing 2021

Oct 20, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MiNK Therapeutics, Inc. (INKT)
CIK: 0001840229
Period of Report: 2021-10-19

Reporting Person: AGENUS INC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-10-19	Common Stock	P	1400000	$12.00	Acquired	20881000	Direct
2021-10-19	Common Stock	C	5451958	—	Disposed	26332958	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-19	Convertible Promissory Note	$	C	5451958	Disposed	2022-07-01	Common Stock (5451958)	Direct

Footnotes

F1: The shares were purchased in this Issuer's initial public offering.

F2: The shares were received upon the automatic conversion of a convertible promissory note issued to Agenus Inc. by the issuer upon completion of the Issuer's initial public offering. The conversion rate of the note was equal to the quotient obtained by dividing (i) the amount due on the date of conversion by (ii) 80% of the per share price of the common stock sold in the initial public offering.